Giving hereditary haemorrhagic telangiectasia the attention it deserves

Abstract

In March, 2021, The Lancet Haematology published an editorial entitled “giving von Willebrand disease the attention it deserves”, 1 The Lancet HaematologyGiving von Willebrand disease the attention it deserves. Lancet Haematol. 2021; 8: e161 Summary Full Text Full Text PDF PubMed Scopus (1) Google Scholar which highlighted the disparity in recognition and treatment advances between von Willebrand disease and haemophilia. This well-reasoned editorial argues that von Willebrand disease, a more common affliction, deserves more clinical and investigative attention than it has received and highlights international clinical guidelines, which were published in 2021, 2 Connell NT Flood VH Brignardello-Petersen R et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021; 5: 301-325 Crossref PubMed Google Scholar , 3 James PD Connell NT Ameer B et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021; 5: 280-300 Crossref PubMed Google Scholar as a welcome step forward in accomplishing these goals.